Cytodyn Inc (CYDY)

[Northstar42]

IDMC recommendation reflects their assessment that interim safety and efficacy data analysis are acceptable. Here is a quote from their website, as to the committee's responsibilities. "An independent data monitoring committee (IDMC) or data and safety monitoring board (DSMB) can play a vital role in protecting patients enrolled in a clinical trial from harm. An IDMC may also review of interim efficacy outcomes in trials with early stopping rules or adaptive designs." Since there is no "early stoppage or adaptive designs", my conclusion is that this is great news regarding safety and excellent news regarding efficacy.